Monoclonal Antibody Therapy

Monoclonal Antibody (mAB) Therapy is a type of immunotherapy. It employs specific antibodies to target cancer cells for removal from the body. This type of therapy relies on the body's own immune system to fight the cancer, rather than attacking the cells with damaging chemotherapy and radiation.

To understand how this therapy works, you must understand what antigens and antibodies are. Antigens are cell markers that are produced in every type of cell – the cells of your body, bacteria, and viruses. These markers are different in every cell type, so your body can tell them apart. Antibodies are designed to bind to antigens, like fitting two puzzle pieces together. Monoclonal antibodies are large groups of antibodies that only bind to one antigen.

In monoclonal antibody therapy, doctors inject patients with antibodies that bind to the antigens on cancer cells. In this way, they are "tagging" the bad cells. When cells are tagged with these antibodies, they are marked for removal by immune cells. Thus, the body removes its own tumors. It is for this reason that mABs are classified as immunotherapy.

Immunotherapy typically does not have the symptoms of chemotherapy and radiation because the body's immune system will not attack healthy cells. Chemotherapy and radiation, on the other hand, attack any type of fast growing cell, even if it's not a tumor. For this reason, immunotherapy is a highly researched and evolving branch of cancer treatment.

It is important to remember that an antibody designed to mark a certain type of cell – a B-cell, let's say – will not work on a T-cell cancer. The antibodies will only bind to one type of antigen, and antigens are cell specific.

In some cases, immunotherapy by itself is not enough. So scientists have found a way to mix the mABs with radiation. By attaching a radionuclide (radioactive molecule) to the antibody, small amounts of radiation can be applied directly to tumors. Since the antibodies will automatically bind the cancer cells, the radiation is delivered to tumors and the damage to healthy cells is minimized. This type of therapy is particularly effective on lymphomas because they are highly sensitive to radiation.

Immunotherapy can be combined with chemotherapy for advanced cancers.

The following are FDA approved mABs. For more information on monoclonal antibodies and a more complete list of FDA-approved drugs, see this article from the Mayo Clinic.

Rituxan (generic name rituximab)
A non-radioactive monoclonal antibody
Zevalin
A radioactive mAB with an yttrium-90 radiolabel

Clinical Trial Locator

Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

More Articles

More Articles

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

Is there such a thing as an average cost of chemotherapy? No. Not even close. In order for there to be an average cost of chemotherapy, one would...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

This entry looks at one of those types of lymphoma sometimes referred to simply as abdominal lymphoma. 'Lymphoma' is an umbrella term that...

Usually, even if a subtype of lymphoma is known to be indolent (slow-growing), it is considered a malignant...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Hodgkin's Lymphoma a.k.a. Hodgkin's Disease is a malignant (cancerous) growth of cells in the lymphatic system...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...